MX2023001410A - Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor. - Google Patents
Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor.Info
- Publication number
- MX2023001410A MX2023001410A MX2023001410A MX2023001410A MX2023001410A MX 2023001410 A MX2023001410 A MX 2023001410A MX 2023001410 A MX2023001410 A MX 2023001410A MX 2023001410 A MX2023001410 A MX 2023001410A MX 2023001410 A MX2023001410 A MX 2023001410A
- Authority
- MX
- Mexico
- Prior art keywords
- intra
- pharmaceutical composition
- articular corticosteroid
- pain control
- corticosteroid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063061395P | 2020-08-05 | 2020-08-05 | |
| PCT/US2021/044619 WO2022031898A1 (en) | 2020-08-05 | 2021-08-05 | Pharmaceutical composition of intra-articular corticosteroid for pain control |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023001410A true MX2023001410A (es) | 2023-03-06 |
Family
ID=77519828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023001410A MX2023001410A (es) | 2020-08-05 | 2021-08-05 | Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12514820B2 (https=) |
| EP (1) | EP4192426A1 (https=) |
| JP (1) | JP2023537474A (https=) |
| KR (1) | KR20230048066A (https=) |
| CN (1) | CN116348093A (https=) |
| AU (1) | AU2021320774A1 (https=) |
| BR (1) | BR112023001926A2 (https=) |
| CA (1) | CA3187955A1 (https=) |
| CL (1) | CL2023000315A1 (https=) |
| IL (1) | IL300354A (https=) |
| MX (1) | MX2023001410A (https=) |
| TW (1) | TW202220668A (https=) |
| WO (1) | WO2022031898A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2854769T1 (sl) * | 2012-07-05 | 2023-09-29 | Taiwan Liposome Company, Ltd. | Postopki za zdravljenje artritisa |
| ES2985871T3 (es) * | 2017-03-14 | 2024-11-07 | Seikagaku Kogyo Co Ltd | Composición para tratar artropatías y kit que incluye la misma |
| EP3849522A1 (en) * | 2018-09-16 | 2021-07-21 | TLC Biopharmaceuticals, Inc. | Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain |
-
2021
- 2021-08-05 KR KR1020237006338A patent/KR20230048066A/ko active Pending
- 2021-08-05 JP JP2023507244A patent/JP2023537474A/ja active Pending
- 2021-08-05 CN CN202180057600.XA patent/CN116348093A/zh active Pending
- 2021-08-05 US US18/040,454 patent/US12514820B2/en active Active
- 2021-08-05 IL IL300354A patent/IL300354A/en unknown
- 2021-08-05 AU AU2021320774A patent/AU2021320774A1/en active Pending
- 2021-08-05 TW TW110128943A patent/TW202220668A/zh unknown
- 2021-08-05 WO PCT/US2021/044619 patent/WO2022031898A1/en not_active Ceased
- 2021-08-05 BR BR112023001926A patent/BR112023001926A2/pt unknown
- 2021-08-05 EP EP21762258.8A patent/EP4192426A1/en active Pending
- 2021-08-05 CA CA3187955A patent/CA3187955A1/en active Pending
- 2021-08-05 MX MX2023001410A patent/MX2023001410A/es unknown
-
2023
- 2023-02-01 CL CL2023000315A patent/CL2023000315A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4192426A1 (en) | 2023-06-14 |
| TW202220668A (zh) | 2022-06-01 |
| KR20230048066A (ko) | 2023-04-10 |
| IL300354A (en) | 2023-04-01 |
| US20230285293A1 (en) | 2023-09-14 |
| JP2023537474A (ja) | 2023-09-01 |
| CN116348093A (zh) | 2023-06-27 |
| US12514820B2 (en) | 2026-01-06 |
| AU2021320774A1 (en) | 2023-03-09 |
| WO2022031898A1 (en) | 2022-02-10 |
| CA3187955A1 (en) | 2022-02-10 |
| CL2023000315A1 (es) | 2023-09-22 |
| BR112023001926A2 (pt) | 2023-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022005994A (es) | Uso del inhibidor de fak en la preparacion de un farmaco para el tratamiento contra tumores con mutacion nras. | |
| ZA202202361B (en) | Treatment of hidradenitis suppurativa using jak inhibitors | |
| PH12021551792A1 (en) | Bi-ligand drug conjugate and use thereof | |
| PH12012501741A1 (en) | Treatment of lupus arthritis using laquinimod | |
| PH12015502691A1 (en) | Use of high dose pridopidine for treating huntington's disease | |
| MX2017006938A (es) | Terapia de combinacion para el tratamiento de cancer. | |
| MX2024011142A (es) | Tratamiento de neurofibromas cutaneos con mirdametinib. | |
| ZA202006072B (en) | Ret inhibitor for use in treating cancer having a ret alteration | |
| MX2022007911A (es) | Procedimiento de tratamiento de una infeccion virica usando un agonista de tlr7. | |
| WO2014160155A3 (en) | Implantable drug delivery compositions comprising non-polymeric sorption enhancers and methods of treatment thereof | |
| MX2020010034A (es) | Metodo de tratamiento de enfermedad fibrotica. | |
| BR112022025920A2 (pt) | Tratamento de artrite reumatoide | |
| BR112022024999A2 (pt) | Inibidor tlr7 em combinação com prednisolona ou hidroxicloroquina para o tratamento do lúpus eritematoso cutâneo | |
| EP1677806A4 (en) | METHOD FOR THE TREATMENT OF ACUTE AND HYALURONIC ACIDIFICATION CAUSED BY EXCESSIVE INJURY AND STUPIDATION | |
| MX2023001410A (es) | Composicion farmaceutica de corticosteroides intraarticulares para el control del dolor. | |
| ZA202101688B (en) | Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain | |
| MX2021002590A (es) | Metodos de uso de un compuesto de fenoxipropilamina para tratar el dolor. | |
| BR112021024835A2 (pt) | Tratamento para sinuclenopatias | |
| BR112022005765A2 (pt) | Tratamento contra afecções espondiloartríticas e psoriáticas com upadacitinib | |
| MX2018005876A (es) | Regimen de dosificacion de plasminogeno para la cicatrizacion de heridas. | |
| Mlachkova et al. | Effectiveness of NSAIDs for pain management in periodontal surgery | |
| AR101227A1 (es) | Combinaciones de un derivado de n-tiazolil-4-fenoxibencenosulfonamida y un agente farmacéuticamente activo seleccionado a partir de gabapentina y pregabalina para tratar dolor | |
| ZA202100604B (en) | Methods to reduce complications of intra-articular steroid | |
| PH12022553441A1 (en) | Compositions and methods for treating obsessive-compulsive disorder | |
| BR112023023702A2 (pt) | Métodos de tratamento da cistite intersticial/síndrome da dor na bexiga |